| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |